ImportRefusal LogoImportRefusal

Laboratorios Bremer, S.A.

⚠️ Moderate Risk

FEI: 3003097030 • Garcia, Nuevo Leon • MEXICO

FEI

FEI Number

3003097030

📍

Location

Garcia, Nuevo Leon

🇲🇽

Country

MEXICO
🏢

Address

Cd Industrial Mitras, Omicron 8116; Garcia, Garcia, Nuevo Leon, Mexico

Moderate Risk

FDA Import Risk Assessment

38.9
LowModerateHighCritical

This firm has a moderate history of FDA import refusals. Some attention may be warranted.

Statistics

9
Total Refusals
10
Unique Violations
3/28/2018
Latest Refusal
12/12/2001
Earliest Refusal

Score Breakdown

Violation Severity
68.0×40%
Refusal Volume
37.0×30%
Recency
0.0×20%
Frequency
5.5×10%
How is this score calculated?

Proprietary Algorithm

  • 40% Violation Severity — AI-assessed (1-10)
  • 30% Refusal Volume — Logarithmic scale
  • 20% Recency — Decays over 5 years
  • 10% Frequency — Refusals per year

© ImportRefusal.com Original Analysis

Violation Summary

756×

UNAPPROVED

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).

164×

DIRECTIONS

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it is a device whose label appears to not bear adequate directions for use.

4712×

CSTIC LBLG

The labeling appears to fail to comply with cosmetic labeling requirements of Section 602(a), and/or (b), and/or (c), and as identified by 21 C.F.R. Part 701.

22802×

DIRSEXMPT

The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a drug within the meaning of Section 201(g) and it lacks adequate directions for use.

4731×

LABELING

The article appears in violation of FPLA because of its placement, form and/or contents statement.

721×

NEW VET DR

The article is subject to refusal of admission pursuant to Section 801(a)(3) of the Federal Food, Drug, and Cosmetic Act in that it appears to be a new animal drug that is unsafe within the meaning of Section 512(a) of the Federal Food, Drug, and Cosmetic Act as it is not the subject of an approved new animal drug application, conditionally approved new animal drug application, or index listing, and no investigational new animal drug exemption applies.

37411×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(o) in that it is being imported or offered for import into the United States, and the importer, owner, or consignee of such article did not, at the time of offering the article for import, submit to the Secretary a statement that identifies the registration under section 510(i) of the Act of each establishment that with respect to such article is required under such section to register with the Secretary.

32801×

FRNMFGREG

The article is subject to refusal of admission pursuant to section 801(a)(3) in that it appears to be misbranded as defined in section 502(o) of the FD&C Act. It appears that it was manufactured, prepared, propagated, compounded, or processed in an establishment not duly registered under section 510 of the Act.

3441×

WARNINGS

It appears to lack adequate warning against use in a pathological condition or by children where it may be dangerous to health or against an unsafe dose, method, administering duration, application, in manner/form, to protect users.

1181×

NOT LISTED

It appears the drug or device is not included in a list required by Section 510(j), or a notice or other information respecting it was not provided as required by section 510(j) or 510(k).

Refusal History

DateProductViolationsDivision
3/28/2018
60LBJ99ANALGESIC, N.E.C.
2280DIRSEXMPT
75UNAPPROVED
Division of Southwest Imports (DSWI)
8/21/2013
62GBJ99ANTI-INFLAMMATORY N.E.C.
118NOT LISTED
16DIRECTIONS
3280FRNMFGREG
3741FRNMFGREG
75UNAPPROVED
Southwest Import District Office (SWI-DO)
4/8/2013
66VAJ99MISCELLANEOUS PATENT MEDICINES, ETC.
2280DIRSEXMPT
75UNAPPROVED
Southwest Import District Office (SWI-DO)
11/14/2012
53LC99OTHER SKIN CARE PREPARATIONS, N.E.C.
471CSTIC LBLG
473LABELING
Southwest Import District Office (SWI-DO)
7/18/2011
53LG08PASTE MASKS (MUD PACKS) (SKIN CARE PREPARATIONS)
471CSTIC LBLG
Southwest Import District Office (SWI-DO)
3/10/2003
53LC03FACE,BODY,AND HAND (EXCLUDING SHAVING PREPARATIONS) (SKIN CARE PREPARATIONS)
16DIRECTIONS
75UNAPPROVED
Southwest Import District Office (SWI-DO)
8/20/2002
66VBJ99MISCELLANEOUS PATENT MEDICINES, ETC.
72NEW VET DR
Southwest Import District Office (SWI-DO)
12/28/2001
60LBJ63SALICYLAMIDE (ANALGESIC)
16DIRECTIONS
75UNAPPROVED
Southwest Import District Office (SWI-DO)
12/12/2001
60LBJ63SALICYLAMIDE (ANALGESIC)
16DIRECTIONS
344WARNINGS
75UNAPPROVED
Southwest Import District Office (SWI-DO)

Frequently Asked Questions

What is Laboratorios Bremer, S.A.'s FDA import refusal history?

Laboratorios Bremer, S.A. (FEI: 3003097030) has 9 FDA import refusal record(s) in our database, spanning from 12/12/2001 to 3/28/2018.

What is an FEI number?

FEI stands for Firm Establishment Identifier. It's a unique number assigned by the FDA to identify establishments that manufacture, process, pack, or hold food, drugs, medical devices, or other FDA-regulated products. Laboratorios Bremer, S.A.'s FEI number is 3003097030.

What types of violations has Laboratorios Bremer, S.A. received?

Laboratorios Bremer, S.A. has been cited for 10 different violation type(s). Common FDA violations include adulteration (unsafe or unsanitary products), misbranding (incorrect or misleading labels), and regulatory non-compliance.

Where does this information about Laboratorios Bremer, S.A. come from?

All FDA import refusal data for Laboratorios Bremer, S.A. is sourced from the official FDA Data Dashboard (datadashboard.fda.gov), a public government database maintained by the U.S. Food and Drug Administration.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.